Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

SPR Detection System

By Drug Discovery Trends Editor | March 5, 2009

FUJIFILM AP-3000FUJIFILM Corporation launched the AP-3000 label-free surface plasmon resonance (SPR) detection system for fragment-based lead discovery (FBLD). The AP-3000 is a high-sensitivity SPR biosensor that can detect small fragments with weak binding affinities accurately, reliably, and reproducibly with high throughput, according to FUJIFILM Corporation.
 
The AP-3000 is capable of the simultaneous measurement of multiple samples (up to six samples), enabling label-free screening of 3,840 samples per day. The system is designed to run all steps of the SPR process unattended.
 
The system optimizes the injection, flow, and measurement of low volume samples, and reduces the amount of protein and compound needed for analysis. The plastic biosensor can be used up to 400 times, thereby reducing running costs.
 
Some of the benefits of the system are: high sensitivity, the system can measure the binding level of small molecules as low as 100 Daltons; high throughput, the binding level of 3,840 analytes can be obtained in 24 hours; automatic process, all processes of preparing the materials, immobilizing proteins, injecting compounds, and obtaining binding data are fully automated; and low sample and running costs, technology to inject and circulate small amounts of samples lowers the amount of proteins and compounds being used while plastic biosensors can be used up to 400 times each, reducing running costs, according to the company.

 https://lifescience.fujifilm.com.


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE